4/A//SEC Filing
Duncan Gregory Scott 4/A
Accession 0001104659-21-047253
CIK 0001818844other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 9:56 PM ET
Size
5.0 KB
Accession
0001104659-21-047253
Insider Transaction Report
Form 4/AAmended
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2021-04-05$6.17/sh+15,675$96,757→ 19,579 total
Footnotes (1)
- [F1]This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001831127
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 9:56 PM ET
- Size
- 5.0 KB